Is the detection of circulating tumor cells in locally advanced pancreatic cancer a useful prognostic marker?

Expert Review of Molecular Diagnostics

Volumn 13, Issue 8, 2013, Pages 793-796

  Gall, Tamara M H ^a   Frampton, Adam E ^a   Krell, Jonathan ^a   Jacob, Jimmy ^a   Stebbing, Justin ^b   Jiao, Long R ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

biomarker; circulating tumor cell; CTC; diagnostic; locally advanced cancer; pancreatic ductal adenocarcinoma; PDAC

Indexed keywords

CAPECITABINE; ERLOTINIB; GEMCITABINE; TUMOR MARKER;

ADVANCED CANCER; ARTICLE; BLOOD; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CIRCULATING TUMOR CELL; CONTROLLED STUDY; DISTANT METASTASIS FREE SURVIVAL; FEMALE; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PANCREAS CANCER; PHASE 3 CLINICAL TRIAL; PRIMARY TUMOR; PROGRESSION FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TUMOR DIFFERENTIATION; TUMOR INVASION;

ADENOCARCINOMA; FEMALE; HUMANS; MALE; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING; PANCREATIC NEOPLASMS;

EID: 84887386562     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.2013.845091     Document Type: Article

References (24)

1. Cen P, Ni X, Yang J, Graham DY, Li M. Circulating tumor cells in the diagnosis and management of pancreatic cancer. Biochim. Biophys. Acta (BBA)-Rev. Cancer 1826(2), 350-356 (2012
2. Valastyan S, Weinberg Robert A. Tumor metastasis: Molecular insights and evolving paradigms. Cell 147(2), 275-292 (2011
3. de Albuquerque A, Kubisch I, Breier G et al. Multimarker gene analysis of circulating tumor cells in pancreatic cancer patients: A feasibility study. Oncology 82(1), 3-10 (2012
4. Ren C, Han C, Zhang J et al. Detection of apoptotic circulating tumor cells in advanced pancreatic cancer following 5-fluorouracil chemotherapy. Cancer Biol. Ther. 12(8), 700-706 (2011
5. Bidard FC, Huguet F, Louvet C et al. Circulating tumor cells in locally advanced pancreatic adenocarcinoma: The ancillary CirCe 07 study to the LAP 07 trial. Ann. Oncol. 24(8), 2057-2061 (2013
6. Tjensvoll K, Nordgard O, Smaaland R. Circulating tumor cells in pancreatic cancer patients: Methods of detection and clinical implications. Int. J. Cancer doi:10.1002/ ijc.28134 (2013) (Epub ahead of print
7. Jacob J, Krell J, Castellano L, Jiao LR, Stebbing J, Frampton AE. Determination of cut-offs for circulating tumor cell measurement in metastatic cancer. Expert Rev. Anticancer Ther. 11(9), 1345-1350 (2011
8. Rahbari NN, Aigner M, Thorlund K et al. Meta-Analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer. Gastroenterology 138(5), 1714-1726 (2010
9. de Bono JS, Scher HI, Montgomery RB et al. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin. Cancer Res. 14(19), 6302-6309 (2008
10. Hou JM, Greystoke A, Lancashire L et al. Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy. Am. J. Pathol. 175(2), 808-816 (2009
11. Galizia G, Gemei M, Orditura M et al. Postoperative detection of circulating tumor cells predicts tumor recurrence in colorectal cancer patients. J. Gastrointest Surg. doi: 10.1007/s11605-013-2258-6 (2013) (Epub ahead of print
12. Bidard F-C, Mathiot C, Delaloge S et al. Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer. Ann. Oncol. 21(4), 729-733 (2010
13. Buglione M, Grisanti S, Almici C et al. Circulating tumour cells in locally advanced head and neck cancer: Preliminary report about their possible role in predicting response to non-surgical treatment and survival. Euro. J. Cancer 48(16), 3019-3026 (2012
14. Gall TM, Jacob J, Frampton AE et al. No-Touch isolation surgical technique reduces dissemination of circulating tumor cells in patients with pancreatic cancer. Pancreatology 13(3), S28 (2013
15. Jiao LR, Apostolopoulos C, Jacob J et al. Unique localization of circulating tumor cells in patients with hepatic metastases. J. Clin. Oncol. 27(36), 6160-6165 (2009
16. Deneve E, Riethdorf S, Ramos J et al. Capture of viable circulating tumor cells in the liver of colorectal cancer patients. Clin. Chem. (2013
17. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 139(5), 871-890 (2009
18. Muller V, Alix-Panabieres C, Pantel K. Insights into minimal residual disease in cancer patients: Implications for anti-cancer therapies. Eur. J. Cancer 46(7), 1189-1197 (2010
19. Rossi E, Basso U, Celadin R et al. M30 neoepitope expression in epithelial cancer: Quantification of apoptosis in circulating tumor cells by CellSearch analysis. Clin. Cancer Res. 16(21), 5233-5243 (2010
20. Paterlini-Brechot P, Benali NL. Circulating tumor cells (CTC) detection: Clinical impact and future directions. Cancer Lett. 253(2), 180-204 (2007
21. Amato RJ, Melnikova V, Zhang Y et al. Epithelial cell adhesion molecule-positive circulating tumor cells as predictive biomarker in patients with prostate cancer. Urology 81(6), 1303-1307 (2013
22. Shamash J, Jacob J, Agrawal S et al. Whole blood stem cell reinfusion and escalated dose melphalan in castration-resistant prostate cancer: A phase 1 study. Clin. Cancer Res. 18(8), 2352-2359 (2012
23. Li C, Heidt DG, Dalerba P et al. Identification of pancreatic cancer stem cells. Cancer Res. 67(3), 1030-1037 (2007
24. Hermann PC, Huber SL, Herrler T et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1(3), 313-323 (2007